FDA denies a petition to exempt certain radiology AI software from 510(k) review, stressing ongoing regulatory oversight.
Key Details
- 1FDA rejected Harrison.ai's petition seeking 510(k) exemption for four types of radiology AI (CADx, CADe, CADt, CADe/x) under specific classifications.
- 2At least 255 radiology AI devices received 510(k) clearance in 2025 alone, per FDA records.
- 3FDA clarified prior clearance does not guarantee manufacturer competence for future device development.
- 4Manufacturer-proposed self-evaluation and risk plans were dismissed due to insufficient FDA oversight mechanisms.
- 5Most public comments opposed the exemption, and FDA detailed significant differences between CADe, CADx, and CADe/x devices impacting regulatory needs.
- 6The agency emphasized vulnerabilities in relying on end-users (radiologists) to catch all performance issues.
Why It Matters
This decision underscores the FDA’s commitment to robust regulatory oversight for radiology AI, potentially affecting product development timelines and market strategies. The nuanced treatment of different device categories and the rejection of broad user detection arguments highlight stringent evidentiary requirements that developers must meet.
Source
AuntMinnie
Related News
•AuntMinnie
LLM Boosts Accuracy and Clarity of Patient Radiology Report Translations
A study found GPT-o1 effectively simplified and accurately translated emergency radiology reports into multiple languages, outperforming Google Translate.
•Radiology Business
AI Rarely Mentioned in Radiology Job Listings Despite Widespread Adoption
A new report finds that AI is rarely specified in radiology job postings, despite its broad use in imaging.
•AuntMinnie
Study Reveals Women's Willingness to Pay for AI in Mammography
Awareness of AI accuracy, error rates, and advertising affect women's out-of-pocket willingness to pay for AI-supported mammography.